|
US7628339B2
(en)
|
1991-04-24 |
2009-12-08 |
Novartis Pharma Ag |
Systems and methods for controlling fluid feed to an aerosol generator
|
|
US6540154B1
(en)
|
1991-04-24 |
2003-04-01 |
Aerogen, Inc. |
Systems and methods for controlling fluid feed to an aerosol generator
|
|
US5983956A
(en)
|
1994-10-03 |
1999-11-16 |
Astra Aktiebolag |
Formulation for inhalation
|
|
US5980949A
(en)
*
|
1994-10-03 |
1999-11-09 |
Astra Aktiebolag |
Formulation for inhalation
|
|
US6427682B1
(en)
|
1995-04-05 |
2002-08-06 |
Aerogen, Inc. |
Methods and apparatus for aerosolizing a substance
|
|
US6205999B1
(en)
|
1995-04-05 |
2001-03-27 |
Aerogen, Inc. |
Methods and apparatus for storing chemical compounds in a portable inhaler
|
|
US5758637A
(en)
|
1995-08-31 |
1998-06-02 |
Aerogen, Inc. |
Liquid dispensing apparatus and methods
|
|
US6085740A
(en)
|
1996-02-21 |
2000-07-11 |
Aerogen, Inc. |
Liquid dispensing apparatus and methods
|
|
US6672304B1
(en)
|
1995-06-08 |
2004-01-06 |
Innovative Devices, Llc |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
|
GB9616047D0
(en)
*
|
1996-07-31 |
1996-09-11 |
Glaxo Group Ltd |
Medicament carrier with agglomerated large medicament particles and related method of manufacture thereof
|
|
US6458574B1
(en)
|
1996-09-12 |
2002-10-01 |
Transkaryotic Therapies, Inc. |
Treatment of a α-galactosidase a deficiency
|
|
US6083725A
(en)
*
|
1996-09-13 |
2000-07-04 |
Transkaryotic Therapies, Inc. |
Tranfected human cells expressing human α-galactosidase A protein
|
|
SE9700135D0
(sv)
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
|
SE9700133D0
(sv)
*
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
|
US6153211A
(en)
*
|
1997-07-18 |
2000-11-28 |
Infimed, Inc. |
Biodegradable macromers for the controlled release of biologically active substances
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
US6433040B1
(en)
*
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
US20020017295A1
(en)
*
|
2000-07-07 |
2002-02-14 |
Weers Jeffry G. |
Phospholipid-based powders for inhalation
|
|
US6946117B1
(en)
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
|
ATE248583T1
(de)
*
|
1997-09-29 |
2003-09-15 |
Nektar Therapeutics |
In dosierinhalatoren verwendbare, stabilisierte zubereitungen
|
|
GEP20043260B
(en)
|
1998-03-16 |
2004-06-25 |
Nectar Therapeutics |
Aerosolized Active Agent Delivery and Device for Realization Thereof
|
|
US6593133B1
(en)
|
1998-07-06 |
2003-07-15 |
Nsgene A/S |
Neurotrophic factors
|
|
US6956021B1
(en)
*
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
|
UA73924C2
(en)
*
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
|
US6660715B2
(en)
|
1998-11-19 |
2003-12-09 |
Massachusetts Institute Of Technology |
Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
|
|
EP2191718A1
(de)
|
1998-12-22 |
2010-06-02 |
The University of North Carolina at Chapel Hill |
Verbindungen und Verwendungen zur Behandlung von Atemwegeserkrankungen sowie zur Verabreichung von Arzneistoffen für die Atemwege
|
|
US20020006901A1
(en)
*
|
1999-02-05 |
2002-01-17 |
Aldo T. Iacono |
Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
|
|
AU779869B2
(en)
|
1999-04-13 |
2005-02-17 |
Nektar Therapeutics |
Pulmonary administration of dry powder formulations for treating infertility
|
|
HK1049621A1
(zh)
|
1999-06-09 |
2003-05-23 |
罗伯特‧E‧希弗斯 |
超临界流体辅助的喷雾和鼓泡乾燥
|
|
US6606992B1
(en)
|
1999-06-30 |
2003-08-19 |
Nektar Therapeutics |
Systems and methods for aerosolizing pharmaceutical formulations
|
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
|
US20010036481A1
(en)
*
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
|
CA2382821A1
(en)
*
|
1999-08-25 |
2001-03-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
|
US6235177B1
(en)
|
1999-09-09 |
2001-05-22 |
Aerogen, Inc. |
Method for the construction of an aperture plate for dispensing liquid droplets
|
|
DE60025019T2
(de)
*
|
1999-10-29 |
2006-08-24 |
Nektar Therapeutics, San Carlos |
Trockenpulverzusammensetzungen mit verbesserter dispersivität
|
|
US20010029947A1
(en)
*
|
1999-12-17 |
2001-10-18 |
Steve Paboojian |
Receptacles to facilitate the extraction of powders
|
|
EP1242112A4
(de)
*
|
1999-12-21 |
2005-02-09 |
Rxkinetix Inc |
Partikel-enthaltende medikamente und methode zu deren herstellung
|
|
US6761909B1
(en)
|
1999-12-21 |
2004-07-13 |
Rxkinetix, Inc. |
Particulate insulin-containing products and method of manufacture
|
|
HUP0203751A3
(en)
|
2000-01-10 |
2005-01-28 |
Maxygen Holdings Ltd Redwood C |
G-csf conjugates
|
|
US7971588B2
(en)
|
2000-05-05 |
2011-07-05 |
Novartis Ag |
Methods and systems for operating an aerosol generator
|
|
US6948491B2
(en)
|
2001-03-20 |
2005-09-27 |
Aerogen, Inc. |
Convertible fluid feed system with comformable reservoir and methods
|
|
MXPA02010884A
(es)
|
2000-05-05 |
2003-03-27 |
Aerogen Ireland Ltd |
Aparato y metodo para el suministro de medicamentos al sistema respiratorio.
|
|
US7100600B2
(en)
|
2001-03-20 |
2006-09-05 |
Aerogen, Inc. |
Fluid filled ampoules and methods for their use in aerosolizers
|
|
US7600511B2
(en)
|
2001-11-01 |
2009-10-13 |
Novartis Pharma Ag |
Apparatus and methods for delivery of medicament to a respiratory system
|
|
US8336545B2
(en)
|
2000-05-05 |
2012-12-25 |
Novartis Pharma Ag |
Methods and systems for operating an aerosol generator
|
|
PT1280520E
(pt)
|
2000-05-10 |
2014-12-16 |
Novartis Ag |
Pós à base de fosfolípidos para administração de fármacos
|
|
US6948494B1
(en)
|
2000-05-10 |
2005-09-27 |
Innovative Devices, Llc. |
Medicament container with same side airflow inlet and outlet and method of use
|
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
|
US6668827B2
(en)
*
|
2000-05-16 |
2003-12-30 |
Nektar Therapeutics |
Systems devices and methods for opening receptacles having a powder to be fluidized
|
|
US6613308B2
(en)
*
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
|
US6514482B1
(en)
|
2000-09-19 |
2003-02-04 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
|
US20020141946A1
(en)
*
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
|
US7442370B2
(en)
|
2001-02-01 |
2008-10-28 |
Biogen Idec Ma Inc. |
Polymer conjugates of mutated neublastin
|
|
EP1366075B1
(de)
|
2001-02-27 |
2009-05-27 |
Maxygen Aps |
Neue interferon-beta-ähnliche moleküle
|
|
US7276580B2
(en)
*
|
2001-03-12 |
2007-10-02 |
Biogen Idec Ma Inc. |
Neurotrophic factors
|
|
US6546927B2
(en)
|
2001-03-13 |
2003-04-15 |
Aerogen, Inc. |
Methods and apparatus for controlling piezoelectric vibration
|
|
US6732944B2
(en)
|
2001-05-02 |
2004-05-11 |
Aerogen, Inc. |
Base isolated nebulizing device and methods
|
|
EG24184A
(en)
*
|
2001-06-15 |
2008-10-08 |
Otsuka Pharma Co Ltd |
Dry powder inhalation system for transpulmonary
|
|
WO2003015747A1
(en)
|
2001-08-13 |
2003-02-27 |
Genomed, Llc |
Method to treat pulmonary hypoplasia in the newborn
|
|
ITMI20012174A1
(it)
*
|
2001-10-18 |
2003-04-18 |
Univ Parma |
Polvere per somministrazione nasale di farmaci
|
|
CA2465675C
(en)
*
|
2001-11-20 |
2008-06-10 |
Advanced Inhalation Research, Inc. |
Improved particulate compositions for pulmonary delivery
|
|
US20030129250A1
(en)
*
|
2001-11-20 |
2003-07-10 |
Advanced Inhalation Research Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
|
TWI324518B
(en)
*
|
2001-12-19 |
2010-05-11 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
|
US7677467B2
(en)
|
2002-01-07 |
2010-03-16 |
Novartis Pharma Ag |
Methods and devices for aerosolizing medicament
|
|
WO2003057291A1
(en)
|
2002-01-07 |
2003-07-17 |
Aerogen, Inc. |
Devices and methods for nebulizing fluids for inhalation
|
|
JP4761709B2
(ja)
|
2002-01-15 |
2011-08-31 |
エアロジェン,インコーポレイテッド |
エアロゾル発生器を作動するための方法およびシステム
|
|
AU2003217950A1
(en)
*
|
2002-03-05 |
2003-09-22 |
Cleveland State University |
Agglomerated particles for aerosol drug delivery
|
|
SI2630954T1
(sl)
*
|
2002-03-20 |
2017-02-28 |
Civitas Therapeutics, Inc. |
Pulmonalno dovajanje za levodopo
|
|
WO2003088961A1
(en)
*
|
2002-04-19 |
2003-10-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
|
|
DK1503788T3
(da)
|
2002-04-25 |
2011-10-17 |
Shire Human Genetic Therapies |
Behandling af alpha-galactosidase A-deficiens
|
|
EP1531795A4
(de)
|
2002-05-02 |
2011-02-23 |
Harvard College |
Formulierungen zur begrenzung der ausbreitung von lungeninfektionen
|
|
US20050220720A1
(en)
*
|
2002-05-02 |
2005-10-06 |
David Edwards |
Formulations limiting spread of pulmonary infections
|
|
US6915962B2
(en)
|
2002-05-20 |
2005-07-12 |
Aerogen, Inc. |
Apparatus for providing aerosol for medical treatment and methods
|
|
US6930137B2
(en)
*
|
2002-05-31 |
2005-08-16 |
Fina Technology, Inc. |
Method of improving blown film processing performance and physical properties
|
|
US7185651B2
(en)
*
|
2002-06-18 |
2007-03-06 |
Nektar Therapeutics |
Flow regulator for aerosol drug delivery and methods
|
|
WO2004037843A2
(en)
*
|
2002-10-25 |
2004-05-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
|
|
JP4571776B2
(ja)
*
|
2002-11-05 |
2010-10-27 |
Jx日鉱日石エネルギー株式会社 |
潤滑油組成物
|
|
HRP20050638A2
(en)
*
|
2002-12-13 |
2007-03-31 |
Otsuka Pharmaceutical Co. |
Inhalation device for transpulmonary administration
|
|
JP5589165B2
(ja)
|
2003-01-31 |
2014-09-17 |
マウント シナイ スクール オブ メディシン オブ ニューヨーク ユニバーシティー |
タンパク質欠損性障害の治療のための併用療法
|
|
EP1897552B1
(de)
|
2003-04-18 |
2009-06-17 |
Biogen Idec MA Inc. |
Polymerkonjugiertes glycosiliertes Neublastin
|
|
US8616195B2
(en)
|
2003-07-18 |
2013-12-31 |
Novartis Ag |
Nebuliser for the production of aerosolized medication
|
|
AU2004266704B2
(en)
|
2003-08-18 |
2012-02-23 |
Parion Sciences, Inc. |
Capped pyrazinoylguanidine sodium channel blockers
|
|
CA2555841A1
(en)
*
|
2004-02-12 |
2005-09-01 |
Nektar Therapeutics |
Interleukin-13 antagonist powders, spray-dried particles, and methods
|
|
US20050207983A1
(en)
*
|
2004-03-05 |
2005-09-22 |
Pulmatrix, Inc. |
Formulations decreasing particle exhalation
|
|
AU2005229434B2
(en)
|
2004-03-30 |
2010-09-30 |
Nsgene A/S |
Therapeutic use of a growth factor, NsG33
|
|
US7290541B2
(en)
|
2004-04-20 |
2007-11-06 |
Aerogen, Inc. |
Aerosol delivery apparatus and method for pressure-assisted breathing systems
|
|
US7267121B2
(en)
|
2004-04-20 |
2007-09-11 |
Aerogen, Inc. |
Aerosol delivery apparatus and method for pressure-assisted breathing systems
|
|
US7946291B2
(en)
|
2004-04-20 |
2011-05-24 |
Novartis Ag |
Ventilation systems and methods employing aerosol generators
|
|
CN101027318B
(zh)
|
2004-07-19 |
2016-05-25 |
比奥孔有限公司 |
胰岛素-低聚物共轭物,制剂及其用途
|
|
WO2006013462A2
(en)
*
|
2004-07-30 |
2006-02-09 |
Nsgene A/S |
Growth factors nsg28, nsg30, and nsg32
|
|
DK1786454T3
(da)
*
|
2004-08-19 |
2010-09-06 |
Biogen Idec Inc |
Neublastinvarianter
|
|
CN101043899B
(zh)
|
2004-08-19 |
2011-03-30 |
比奥根艾迪克Ma公司 |
重折叠转化型生长因子beta家族蛋白
|
|
UA95446C2
(ru)
|
2005-05-04 |
2011-08-10 |
Іллюміджен Байосайєнсіз, Інк. |
Мутаци в генах oas1
|
|
EP3782655A1
(de)
|
2005-05-17 |
2021-02-24 |
Amicus Therapeutics, Inc. |
Verfahren zur behandlung der pompe-krankheit unter verwendung von 1-deoxynojirimycin und derivaten
|
|
WO2006125153A2
(en)
*
|
2005-05-18 |
2006-11-23 |
Pulmatrix Inc. |
Formulations for alteration of biophysical properties of mucosal lining
|
|
NZ563360A
(en)
|
2005-05-25 |
2011-04-29 |
Aerogen Inc |
Aerosolising liquid using an apertured membrane aligned within a peizoelectric ring
|
|
US7474379B2
(en)
*
|
2005-06-28 |
2009-01-06 |
Asml Netherlands B.V. |
Lithographic apparatus and device manufacturing method
|
|
WO2007016643A2
(en)
*
|
2005-08-01 |
2007-02-08 |
Mount Sinai School Of Medicine Of New York University |
A method for extending longevity using npc1l1 antagonists
|
|
DE602006009418D1
(de)
|
2005-11-21 |
2009-11-05 |
Mannkind Corp |
Pulverabgabe und -erfassungsvorrichtung und -verfahren
|
|
WO2007098507A2
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
TWI501774B
(zh)
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
神經性病症之治療
|
|
US20100056440A1
(en)
*
|
2006-03-01 |
2010-03-04 |
Biogen Idec Ma Inc. |
Compositions and methods for administering gdnf ligand family proteins
|
|
TWI445544B
(zh)
|
2007-05-01 |
2014-07-21 |
Biogen Idec Inc |
增進血管形成之組合物及方法
|
|
US20110135648A1
(en)
*
|
2007-08-08 |
2011-06-09 |
Biogen Idec Ma Inc. |
Anti-neublastin antibodies and uses thereof
|
|
WO2009139948A1
(en)
|
2008-02-26 |
2009-11-19 |
Johnson Michael R |
Poly aromatic sodium channel blockers
|
|
KR20110040979A
(ko)
|
2008-08-05 |
2011-04-20 |
맨카인드 코포레이션 |
개선된 분말 분배기 모듈 및 분말 분배기 조립체
|
|
EP2344200A2
(de)
*
|
2008-09-19 |
2011-07-20 |
Nektar Therapeutics |
Modifizierte therapeutische peptide, herstellungsverfahren und verwendung
|
|
EP2350118B1
(de)
|
2008-09-19 |
2016-03-30 |
Nektar Therapeutics |
Kohlenhydratbasisierte polymere zur wirkstoffabgabe und konjugate davon
|
|
PL2389372T3
(pl)
|
2009-01-23 |
2016-02-29 |
Rigel Pharmaceuticals Inc |
Kompozycje i sposoby hamowania szlaku JAK
|
|
JP5645918B2
(ja)
|
2009-04-09 |
2014-12-24 |
アミカス セラピューティックス インコーポレイテッド |
リソソーム蓄積障害の予防および/または治療方法
|
|
EP2440251A4
(de)
|
2009-06-09 |
2013-01-16 |
Defyrus Inc |
Verabreichung von interferon zur prophylaxe gegen oder zur behandlung von krankheitserregenden infektionen
|
|
WO2011049737A1
(en)
|
2009-10-19 |
2011-04-28 |
Amicus Therapeutics, Inc. |
Novel compositions for preventing and/or treating lysosomal storage disorders
|
|
RU2015147509A
(ru)
|
2009-10-19 |
2019-01-14 |
Амикус Терапьютикс, Инк. |
Новые композиции для предупреждения и/или лечения дегенеративных расстройств центральной нервной системы
|
|
WO2011092690A1
(en)
|
2010-01-26 |
2011-08-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Compositions and methods for prevention and treatment of pulmonary hypertension
|
|
EP2580242B1
(de)
|
2010-06-14 |
2016-04-06 |
H. Lundbeck A/S |
Modulation der interaktion zwischen ligandrezeptoren der sorla- und gdnf-familie
|
|
US8758824B2
(en)
|
2010-08-30 |
2014-06-24 |
Pulmatrix, Inc. |
Respirably dry powder comprising calcium lactate, sodium chloride and leucine
|
|
WO2012030664A1
(en)
|
2010-08-30 |
2012-03-08 |
Pulmatrix, Inc. |
Dry powder formulations and methods for treating pulmonary diseases
|
|
EP4008326A1
(de)
|
2010-09-29 |
2022-06-08 |
Pulmatrix Operating Company, Inc. |
Einwertige metallkationen-trockenpulver zum inhalieren
|
|
PT2621488T
(pt)
|
2010-09-29 |
2019-02-12 |
Pulmatrix Operating Co Inc |
Pós secos catiónicos
|
|
CA2754237A1
(en)
|
2011-05-27 |
2012-11-27 |
The Regents Of The University Of California |
Cyanoquinoline compounds having activity in correcting mutant-cftr processing and increasing ion transport and uses thereof
|
|
SI2723176T1
(sl)
|
2011-06-27 |
2017-09-29 |
Parion Sciences, Inc. |
Kemijsko in metabolno stabilni dipeptid, ki ima močno aktivnost blokiranja natrijevega kanala
|
|
US20130096170A1
(en)
|
2011-10-14 |
2013-04-18 |
Hospira, Inc. |
Methods of treating pediatric patients using dexmedetomidine
|
|
US8242158B1
(en)
|
2012-01-04 |
2012-08-14 |
Hospira, Inc. |
Dexmedetomidine premix formulation
|
|
US20150136130A1
(en)
|
2012-02-29 |
2015-05-21 |
Pulmatrix, Inc. |
Inhalable dry powders
|
|
CA2809279C
(en)
*
|
2012-03-23 |
2014-05-06 |
Pharma 73 S.A. |
Natural biocomposite powder prepared from pichia pastoris biomass, method of preparation and its use as excipient
|
|
WO2013142038A2
(en)
|
2012-03-23 |
2013-09-26 |
Oxigene, Inc. |
Compositions and methods for inhibition of cathepsins
|
|
MX354127B
(es)
|
2012-03-27 |
2018-02-14 |
Amicus Therapeutics Inc |
Compuestos novedosos para prevenir y/o tratar tesaurismosis lisosomicas y/o trastornos degenerativos del sistema nervioso central.
|
|
KR20150135328A
(ko)
|
2013-04-01 |
2015-12-02 |
풀매트릭스 인코퍼레이티드 |
티오트로피움 건조 분말
|
|
CA2939380A1
(en)
|
2014-02-12 |
2015-08-20 |
Amicus Therapeutics, Inc. |
Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of mps iiic
|
|
US9675627B2
(en)
|
2014-04-14 |
2017-06-13 |
Amicus Therapeutics, Inc. |
Dosing regimens for treating and/or preventing cerebral amyloidoses
|
|
AU2015263025A1
(en)
|
2014-05-21 |
2017-01-12 |
Pharma73, S.A. |
Chitin-glucan complex, its preparation, and uses
|
|
KR101746911B1
(ko)
|
2014-12-26 |
2017-06-28 |
주식회사 종근당 |
활성성분의 입도 및 활성성분을 포함하는 과립의 입도가 이중으로 조절된 약제학적 조성물
|
|
US10179128B2
(en)
|
2015-08-31 |
2019-01-15 |
Amicus Therapeutics, Inc. |
Regimens for treating and preventing lysosomal disorders and degenerative disorders of the central nervous system
|
|
NL2017294B1
(en)
|
2016-08-05 |
2018-02-14 |
Univ Erasmus Med Ct Rotterdam |
Natural cryptic exon removal by pairs of antisense oligonucleotides.
|
|
IL267689B2
(en)
|
2016-12-31 |
2025-05-01 |
Bioxcel Therapeutics Inc |
Use of sublingual dexmedetomidine for the treatment of agitation
|
|
KR20190134807A
(ko)
|
2017-04-25 |
2019-12-04 |
아미쿠스 세라퓨틱스, 인코포레이티드 |
중추 신경계의 퇴행성 질환 및/또는 리소솜 저장병을 예방 및/또는 치료하기 위한 신규한 조성물
|
|
IL279713B2
(en)
|
2018-06-27 |
2025-01-01 |
Bioxcel Therapeutics Inc |
Dexmedetomidine-containing layer compositions and methods for their production
|
|
US11160791B2
(en)
|
2018-11-01 |
2021-11-02 |
Medefil, Inc. |
Dexmedetomidine injection premix formulation in ready to use (RTU) bags
|
|
US20220000880A1
(en)
|
2018-11-01 |
2022-01-06 |
Rigel Pharmaceuticals, Inc. |
Method and composition embodiments for treating acute myeloid leukemia
|
|
US20200377518A1
(en)
|
2019-05-29 |
2020-12-03 |
Rigel Pharmaceuticals, Inc. |
Method of preventing and treating thrombosis
|
|
EP3999058A4
(de)
|
2019-07-19 |
2023-05-03 |
Bioxcel Therapeutics, Inc. |
Behandlungsschemata für nicht-sedierendes dexmedetomidin
|
|
EP4009974A1
(de)
|
2019-08-08 |
2022-06-15 |
Rigel Pharmaceuticals, Inc. |
Verbindungen und verfahren zur behandlung des zytokinfreisetzungssyndroms
|
|
CA3147444A1
(en)
|
2019-08-14 |
2021-02-18 |
Rigel Pharmaceuticals, Inc. |
Method of blocking or ameliorating cytokine release syndrome
|
|
WO2022006051A1
(en)
|
2020-06-29 |
2022-01-06 |
Anovent Pharmaceutical (U.S.), Llc |
Formulation of tocilizumab and method for treating covid-19 by inhalation
|
|
ES3075943T3
(en)
|
2022-03-23 |
2026-08-10 |
Rigel Pharmaceuticals Inc |
Pyrimid-2-yl-pyrazole compounds as irak inhibitors
|
|
US11806334B1
(en)
|
2023-01-12 |
2023-11-07 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|